TrialSignal
Clinical trial intelligence report
Testing the Gravitostat in Humans: the Impact of a Weighted Vest in Patients Post Bariatric Surgery on Fat-free Mass Retention and Weight Loss
Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.
Generated
Jul 28, 2026
Report code
NCT04809129-Jul 28, 2026
NCT ID
NCT04809129
Status
SUSPENDED
Phase
Not Applicable
Sponsor
University College Dublin
Executive brief
Investment-Ready Snapshot
The trial, sponsored by University College Dublin, aims to explore the impact of a weighted vest on fat-free mass retention and weight loss in patients post-bariatric surgery. Given the rising prevalence of obesity and the increasing number of bariatric surgeries performed globally, successful outcomes from this study could position the findings as a novel adjunctive therapy in weight management. The market for obesity treatments is substantial, with a growing demand for effective post-operative care solutions. However, the trial's suspension due to funding issues raises concerns regarding its viability and the potential for future commercialization. Competitors in the obesity management space may include pharmaceutical interventions and other non-invasive devices, necessitating a thorough competitive analysis.
Source & freshness
Provenance
https://clinicaltrials.gov/study/NCT04809129
Indication
Obesity
Modality
medical device
Target
Gravitostat mechanism related to fat mass homeostasis and weight control in post-bariatric surgery patients.
Intervention
Weighted vest
Source record
Protocol Description
Detailed source ingestion pending.
Source record
Outcome Measures
Detailed source ingestion pending.
Source record
Eligibility
Detailed source ingestion pending.
AI analysis
Known Results And Readout Context
Detailed source ingestion pending.
IP intelligence
Patent And IP Landscape
Detailed source ingestion pending.
Source record
Contacts
Detailed source ingestion pending.